Pulmonary Artery Denervation for Medication Refractory Pulmonary Hypertension (PARPH Study) ― Study Protocol for a Prospective, Open-Label, Single-Arm Clinical Trial ―
The findings of this study will lead to the adoption of PADN for patients with limited treatment options.
Authors
- Akihiro Tsuji (ORCID: https://orcid.org/0000-0002-3280-6119)
- Mayumi Fukuda‐Doi (ORCID: https://orcid.org/0000-0003-0922-4417)
- Yuko Inoue
- Takeshi Ogo
- Tatsuo Aoki
- Koko Asakura
- KENGO FUKUSHIMA KUSANO (ORCID: https://orcid.org/0000-0002-5760-9285)
- Ryotaro Asano (ORCID: https://orcid.org/0000-0003-0303-6546)
- Satoshi Nagase (ORCID: https://orcid.org/0000-0001-7894-0914)
- Haruko Yamamoto (ORCID: https://orcid.org/0000-0002-8135-2547)
- Jin Ueda (ORCID: https://orcid.org/0000-0002-3942-8499)
Institutions
- Kawasaki Medical School (JP)
- National Cerebral and Cardiovascular Center (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1253/circrep.cr-24-0179
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cerebral and Cardiovascular Center
- Japan Society for the Promotion of Science